logo
CPO prices expected to remain firm in 2025

CPO prices expected to remain firm in 2025

The Star2 days ago
MBSB Research expects the CPO price to average at RM4,100 a tonne in 2025.
PETALING JAYA: Crude palm oil (CPO) prices remain supported by bullish fundamentals and higher demand from price-sensitive markets like Pakistan and India, despite signs of production and stock levels rising.
Indonesia's plans to roll out a B50 biodiesel mandate in 2026 and call on local producers to raise sales in the domestic market are supportive of CPO prices, CGS International Research (CGSI Research) noted.
'We view the recent price support from Indonesia's biodiesel and Domestic Market Obligation measures is likely to be temporary, while ample global vegetable oil supply and sluggish demand fundamentals should continue to cap meaningful upside in CPO prices,' the research house stated in a report.
It expects sustained earnings from pure upstream plantation players given current CPO is holding around the RM4,200 per tonne price level.
Malaysia's CPO stock level rose to a 19-month high of 2.1 million tonnes in July as production rose 7.1% and exports eased to 1.3 million tonnes, down some 22.9% year-on-year (y-o-y).
The fall in exports came despite a widening price premium over soybean oil in July at US$332 per tonne.
Furthermore, MBSB Research noted that despite the July discount premium being 55% above the three-year average of US$214 per tonne, demand for CPO remained muted.
It expects the premium risk to ease as fresh fruit bunches and CPO output continue to recover amid ample stock levels.
It expects the CPO price to average at RM4,100 a tonne for 2025.
Malaysia's CPO production is forecast to rebound in 2025, as the year-to-date production of 10.77 million tonnes is running at 4% above the 10-year January-to-July output of 10.35 million tonnes.
Oilworld, a source of independent global market analyses and forecasts, is expecting the country's total production to hit 19.3 million tonnes while the US Department of Agriculture is forecasting 19.4 million tonnes output.
Kenanga Research is of the view that Malaysia's 2025 CPO production will hit 19.2 million tonnes, which is above the historical 10-year average of 19 million tonnes.
It expects demand supply fundamentals of the global edible oil market to support CPO prices in 2025 and 2026.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bursa Malaysia opens little changed on Friday ahead of GDP data, flat trading on Wall St
Bursa Malaysia opens little changed on Friday ahead of GDP data, flat trading on Wall St

The Star

time29 minutes ago

  • The Star

Bursa Malaysia opens little changed on Friday ahead of GDP data, flat trading on Wall St

KUALA LUMPUR: Investors on Bursa Malaysia held their positions on Friday as the flattish performance on US markets overnight gave little indication on trading direction. The local bourse entered profit-taking mode yesterday as investors cashed in on a seven-day winning streak, but remained little moved at Friday's opening, ahead of Malaysia's economic report due out at noon. Traders snapped up equities over the past two weeks as risk appetite was buoyed by the continuation of US-China trade talks and investors' surging hopes for a US rate cut after a lower-than-expected inflation report. Throwing a spannar in the works, however, was the US producer's price index for July, which showed a 0.9% increase - above the 0.2% forecast by economists - which pointed to rising inflation. As at 9.10am, domestic traders remained uncertain in the absence of trading direction. The FBM KLCI was down 0.45 points to 1,580.6 while the broader market had a nearly even spread of advancers and decliners. "The local benchmark index is expected to extend its profit-taking consolidation phase, as market sentiment should remain subdued while investors await crucial domestic and U.S. data releases ahead of the weekend," said TA Securities in its daily review. Meanwhile, Rakuten Trade said in a note that foreign funds remained net sellers of local equities, which serves as a market dampener. "For today, we expect the index to hover between the 1,575-1,585 range," it added. In early trading, PETRONAS Chemicals dropped seven sne to RM3.57 while PPB shed seven sen to RM8.94 and IOI fell four sen to RM3.81. Nestle gained 26 sen to RM88.06, while PETRONAS Gas rose six sen to RM18.76 and MISC added five sen to RM7.81. Leading actives included TWL flat at 2.5 sen, Oxford Innotech up 0.5 sen to 41.5 sen and Oriental Kopi dipping one sen to 97.5 sen.

Trading ideas: Chin Hin, Sime Property, Catcha, Aemulus, Bursa, Malakoff, JS Solar, Cuckoo, Keyfield, I-Bhd, MNRB, Swift, JPG, N2N
Trading ideas: Chin Hin, Sime Property, Catcha, Aemulus, Bursa, Malakoff, JS Solar, Cuckoo, Keyfield, I-Bhd, MNRB, Swift, JPG, N2N

The Star

timean hour ago

  • The Star

Trading ideas: Chin Hin, Sime Property, Catcha, Aemulus, Bursa, Malakoff, JS Solar, Cuckoo, Keyfield, I-Bhd, MNRB, Swift, JPG, N2N

KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia. Chin Hin Group Property Bhd is disposing of its entire equity interest in four subsidiaries involved in the commercial vehicles and bodyworks segment to N&K Resources (M) Sdn Bhd for RM74mn. Sime Darby Property Bhd is in talks with banks for a loan of up to RM3bn (US$714mn) to fund the construction of a data centre to be leased to Google, according to sources. Catcha Digital Bhd will acquire a 60% stake in One International Exhibition Sdn Bhd for RM11.4mn cash via its wholly owned unit Catcha Connect Sdn Bhd. Aemulus Holdings Bhd will acquire the camera sensor testing business of China-based Revotronix group for RMB32.46mn (RM19.1mn). Bursa Malaysia Bhd has appointed Datuk Mohamed Rafique Merican as independent non-executive director effective Aug 15, 2025. Malakoff Corp Bhd has appointed Syahrunizam Samsudin as group CEO effective Sept 1, succeeding Anwar Syahrin Abdul Ajib, who is stepping down after nearly five years as MD and group CEO. JS Solar Holding Bhd has signed an agreement with TA Securities Holdings Bhd to underwrite 35.75mn shares for its ACE Market listing targeted for 3Q2025. Cuckoo International (Mal) Bhd posted a 1.8% QoQ decline in 2QFY2025 net profit to RM27.4mn, mainly due to listing expenses of RM4.7mn and higher net impairment losses on financial instruments. Keyfield International Bhd posted a net profit of RM66.4mn in 2QFY25, down 5.2% YoY from RM70.0mn, mainly due to fewer chartered days for both own and third-party vessels. I-Bhd more than doubled its 2QFY2025 net profit to RM11.5mn (+110% YoY) on stronger contributions from leisure and hospitality, property development, and property investment. MNRB Holdings Bhd posted a record-high 1QFY2026 net profit of RM168.4mn (+82.7% YoY), driven by strong insurance/takaful revenue growth and favourable claims experience. Swift Haulage Bhd posted a 19% YoY drop in 2QFY2025 net profit to RM6.8mn, weighed down by higher expenses despite stronger revenue. Johor Plantations Group Bhd posted a 51% YoY rise in 2QFY2025 net profit to RM75.2mn on higher CPO and PK delivery volumes and stronger OCP purchases. N2N Connect Bhd posted a 41% YoY increase in 2QFY2025 net profit to RM3.2mn, boosted by lower operating expenses and higher associate contributions.

IHH eyes upside with Turkiye hospital acquisition
IHH eyes upside with Turkiye hospital acquisition

The Star

time3 hours ago

  • The Star

IHH eyes upside with Turkiye hospital acquisition

PETALING JAYA: Turkiye remains a growth engine for IHH Healthcare Bhd , underpinned by the strong occupancy rate of its hospitals there. BIMB Research in a report said Turkiye's largest hospital operator, Acibadem, which is majority-owned by IHH Healthcare Bhd, is operating at 75% occupancy. Revenue in the first quarter of financial year 2025 (1Q25) per inpatient admission rose 16% year-on-year on a constant currency basis to RM12,355, driven by a more acute case mix. 'Inpatient admissions totalled 44,311 in 1Q25, with foreign patients contributing 13% of revenue.' The research house said earnings before interest, taxes, depreciation and amortisation (Ebitda) for Turkiye came in at RM362mil, with a 300 basis points margin drop due to pre-operating costs from Acibadem Kartal and Vitosha, as well as Ramadan seasonality. Looking ahead, growth will be supported by the Bayındır acquisition. 'The Bayındır acquisition brings urban market exposure and potential procurement and operational synergies, and is supported by a pipeline to add 1,030 beds (circa additional 16%) by 2028, in line with rising demand for quality healthcare.' Acibadem announced earlier this week that it had agreed to buy an 80% stake in Bayındır Hospitals from Is Bankasi for US$55mil (RM232.2mil). BIMB Research said the acquisition offers Acibadem immediate capacity expansion, access to new catchment areas, and synergies in procurement and clinical standards, while also tapping into Turkiye's growing healthcare demand, supported by demographic trends and government initiatives. 'Retaining Turkiye Is Bankasi as a minority shareholder reduces political and operational risks while leveraging its local expertise. 'This transaction also strengthens IHH's diversification outside Malaysia, increasing its resilience against market-specific shocks.' BIMB Research said the financial impact to IHH in the near term is likely modest due to the relatively small scale of Bayındır's operations within the group. 'Integration risks remain, especially in aligning systems, regulatory compliance, and corporate culture. 'The deal comes amid continued Turkyish lira volatility, which may affect earnings translation. Nonetheless, the acquisition price appears reasonable given the asset scale and strategic location, though further disclosures on Bayındır's revenue, Ebitda and occupancy rates would help in refining our forecasts.' The research house is maintaining a 'buy' call on IHH with an unchanged target price of RM8.60. 'At this stage, we maintain our financial year 2025 (FY25) to FY26 forecasts pending completion and integration updates. 'The acquisition supports IHH's long-term growth profile but does not immediately alter earnings trajectory. 'Key monitors include post-merger performance, patient volumes, margin trends, and foreign exchange management. 'Given the group's strong balance sheet and execution track record in cross-border acquisitions, we view the move as a strategic positive but will reassess our target price upon receiving more financial details from management.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store